Investors & Media

SEC Filing Details

Document Details

Form
UPLOAD
Filing Date
Aug 3, 2021
Document Date
Aug 3, 2021
Form Description
UPLOAD
Filing Group
Other
Company
Entasis Therapeutics Holdings Inc.
Issuer
ENTASIS THERAPEUTICS HOLDINGS INC.

"Antibiotic resistance is a worldwide problem that is constantly growing. New forms of resistance can spread quickly and across continents. At Entasis, we discover and develop novel antibacterials to address the serious medical need posed by multi-drug resistant bacterial infections."

— Ruben Tommasi, Chief Scientific Officer